▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4089 by analyst upside · 2026-09-29
AVTR
Avantor, Inc.
Healthcare · Market Cap $10B · P/E 0x
ANALYST PRICE TARGET
-4.1%
implied upside to consensus target
Current Price $15.29
Consensus Target $14.66
Bull Target $19.0
Bear Target $12.0
Analysts Covering 15
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
11
Sell
1
52-Week Low $7.26
52-Week High $16.05
YTD Return +33.4%
FUNDAMENTALS
Market Cap $10B
P/E Ratio (TTM) N/A
Forward P/E 17.3x
EPS (TTM) $-0.85
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $6.6B
Profit Margin -8.8%
52-WEEK RANGE
52-Week Low $7.26
52-Week High $16.05
Current Price $15.29
Bear Target $12.0
Bull Target $19.0
● Now $15.29 ● Target $14.66
TRADING DATA
Avg Volume 9.4M
YTD Return +33.4%
Analyst Count 15
Consensus Hold
Upside to Target -4.1%
Last Updated 2026-09-29

ANALYST SUMMARY

Avantor, Inc. (AVTR) is currently trading at $15.29 with a Wall Street consensus price target of $14.66, which is 4.1% below the current price over the next 12 months. 15 analysts currently cover AVTR, with a consensus rating of Hold - 20% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $19.0, while the most cautious has a target of $12.0.

AVTR operates in the Healthcare sector with a market capitalisation of $10B. The stock is up 33.4% year-to-date and is currently trading near the upper end of its 52-week range of $7.26 – $16.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

UHS +9.5%
Universal Health Services, Inc.
$10B · P/E 7.2x · Hold
CAI -11.3%
Caris Life Sciences, Inc.
$9B · P/E 3.3x · Buy
FMS +10.1%
Fresenius Medical Care AG
$12B · P/E 12.0x · Hold
DVA +23.5%
DaVita Inc.
$11B · P/E 15.1x · Hold
COO +17.0%
The Cooper Companies, Inc.
$11B · P/E 19.0x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for AVTR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Neutral → Neutral 2026-09-09 33% win rate (6 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-07-30 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-07-30 Building track record
Stifel - Reiterated
Hold → Hold 2026-07-30 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-07-30 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-07-30 Building track record
Citigroup - Reiterated
Neutral → Neutral 2026-07-08 Building track record
Evercore ISI Group - Reiterated
In-Line → In-Line 2026-07-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
21/30
Consensus clarity
21/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →